Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

News   Jan 11, 2018 | Original story from National Institutes of Health

 
Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

The round, spiked objects at center are MERS coronavirus particles. Credit: NIAID

 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Studying Ebola-Host Cell Interaction Helps Find Targets for Antiviral Drugs

News

In some ways, the Ebola virus operates like a vampire; only after it is politely invited in to a host cell does it take up the task of destroying everything in its path. In a new study researchers seek to elucidate quantitatively the biomechanical mechanism of Ebola-host cell interaction, providing potential new targets for antiviral drug development.

READ MORE

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE